Simultaneously targeting inflammatory response and parasite sequestration in brain to treat Experimental Cerebral Malaria

Olfactory Plays a Key Role in Spatiotemporal Pathogenesis of Cerebral Malaria

(2014) Hong Zhao et al.   Cell Host & Microbe

Chemokine Gene Expression during Fatal Murine Cerebral Malaria and Protection Due to CXCR3 Deficiency

(2014) J. Miu et al.   JOURNAL OF IMMUNOLOGY

Vitamin D Inhibits the Occurrence of Experimental Cerebral Malaria in Mice by Suppressing the Host Inflammatory Response

(2014) X. He et al.   JOURNAL OF IMMUNOLOGY

Targeting the olfactory bulb during experimental cerebral malaria

(2014) Laurent Rénia et al.   TRENDS IN PARASITOLOGY

Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice

(2014) Sahdeo Prasad et al.   Cancer Research and Treatment

Modulation of cerebral malaria by curcumin as an adjunctive therapy

(2013) Kunal Jain et al.   Brazilian Journal of Infectious Diseases

Pharmacologic Inhibition of CXCL10 in Combination with Anti-malarial Therapy Eliminates Mortality Associated with Murine Model of Cerebral Malaria

(2013) Nana O. Wilson et al.   PLoS One

Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model

(2012) Jean-Baptiste Souraud et al.   MALARIA JOURNAL

Curcumin-Arteether Combination Therapy of Plasmodium berghei-Infected Mice Prevents Recrudescence Through Immunomodulation

(2012) Palakkod G. Vathsala et al.   PLoS One

Testing in Mice the Hypothesis That Melanin Is Protective in Malaria Infections

(2012) Michael Waisberg et al.   PLoS One

Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver

(2012) N. Sehgal et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Role of Animal Models for Research on Severe Malaria

(2012) Alister G. Craig et al.   PLoS Pathogens

Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice

(2011) Feroz Akhtar et al.   BIOTECHNOLOGY ADVANCES

Curcumin Modulates Nuclear Factor κB (NF-κB)-mediated Inflammation in Human Tenocytesin Vitro

(2011) Constanze Buhrmann et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malaria

(2011) Patrice N Mimche et al.   MALARIA JOURNAL

CD8+ T Cells and IFN-γ Mediate the Time-Dependent Accumulation of Infected Red Blood Cells in Deep Organs during Experimental Cerebral Malaria

(2011) Carla Claser et al.   PLoS One

Modulation of cerebral malaria by fasudil and other immune-modifying compounds

(2010) Judith H. Waknine-Grinberg et al.   EXPERIMENTAL PARASITOLOGY

Accumulation of Plasmodium berghei-Infected Red Blood Cells in the Brain Is Crucial for the Development of Cerebral Malaria in Mice

(2010) F. G. Baptista et al.   INFECTION AND IMMUNITY

Cerebral Malaria: Mechanisms of Brain Injury and Strategies for Improved Neurocognitive Outcome

(2010) Richard Idro et al.   PEDIATRIC RESEARCH

Neuropathogenesis of human and murine malaria

(2010) Eleanor M. Riley et al.   TRENDS IN PARASITOLOGY

The murine cerebral malaria phenomenon

(2009) Nicholas J. White et al.   TRENDS IN PARASITOLOGY

The Nuclear Factor NF- B Pathway in Inflammation

(2009) T. Lawrence   Cold Spring Harbor Perspectives in Biology

IP-10-Mediated T Cell Homing Promotes Cerebral Inflammation over Splenic Immunity to Malaria Infection

(2009) Catherine Q. Nie et al.   PLoS Pathogens

Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects

(2008) S. K. Vareed et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India

(2008) Vidhan Jain et al.   MALARIA JOURNAL

Control of pathogenic CD8+T cell migration to the brain by IFN-γ during experimental cerebral malaria

(2008) E. BELNOUE et al.   PARASITE IMMUNOLOGY

Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria

(2008) G. S. V. Campanella et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA